Bayer/J&J stroke drug not ready for approval-US FDA

WASHINGTON (Reuters) - U.S. drug regulators said an experimental stroke preventer from Bayer and Johnson & Johnson is not ready for approval and raised questions about its effectiveness, sending Bayer shares down more than 7 percent.

. Read More

Free Web Hosting